Invention Grant
US07385085B2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
失效
肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂
- Patent Title: Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
- Patent Title (中): 肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂
-
Application No.: US11177324Application Date: 2005-07-11
-
Publication No.: US07385085B2Publication Date: 2008-06-10
- Inventor: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
- Applicant: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
- Applicant Address: US CA South San Francisco
- Assignee: Elan Pharmaceuticals, Inc.
- Current Assignee: Elan Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Main IPC: C07C237/04
- IPC: C07C237/04
Abstract:
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
Public/Granted literature
- US20070149584A9 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors Public/Granted day:2007-06-28
Information query
